Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option

Jeffrey H. Lipton, Tim H. Brümmendorf, Carlo Gambacorti-Passerini, Valentin Garcia-Gutiérrez, Michael W. Deininger, Jorge E. Cortes

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option'. Together they form a unique fingerprint.

Medicine & Life Sciences